Cyp60 Inhibitors
The chemical class known as Cyp60 Inhibitors encompasses a diverse array of compounds that exert inhibitory effects on the Cyp60 protein, primarily through their interactions with cytochrome P450 (CYP) enzymes. These inhibitors, exemplified by ketoconazole, clotrimazole, and itraconazole among others, are primarily employed as antifungal agents but possess the secondary function of blocking CYP enzymes, including certain Cyp60 isoforms. Through this inhibition, they disrupt the enzymatic activity of Cyp60, which is integral to various metabolic pathways within the cell. By interfering with these pathways, these inhibitors can effectively hinder the function of the Cyp60 protein, potentially altering its role in cellular metabolism and signaling processes.
Furthermore, compounds like fluoxetine, fluvoxamine, and ritonavir also contribute to the inhibition of Cyp60 indirectly through their inhibition of CYP enzymes. Although not primarily designed as Cyp60 inhibitors, these chemicals exhibit overlapping substrate specificity with Cyp60 isoforms, leading to interference with their enzymatic activity. Consequently, these inhibitors disrupt metabolic pathways crucial for the proper functioning of Cyp60, thereby influencing its activity within the cellular milieu.
While direct inhibitors specifically targeting Cyp60 may not be readily available, these compounds offer valuable insights into potential strategies for modulating Cyp60 function through indirect means. Further elucidation of the precise mechanisms underlying the interactions between these inhibitors and Cyp60 isoforms is essential for understanding their implications and potential applications in various fields, including pharmacology and drug development. Additionally, continued research into the biochemical and physiological roles of Cyp60 will provide a deeper understanding of its significance in cellular processes and facilitate the identification of novel inhibitors targeting this protein.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Ketoconazole is an antifungal agent that inhibits cytochrome P450 enzymes, including some CYP60 isoforms. By blocking the activity of CYP60 enzymes, ketoconazole disrupts their role in metabolic pathways, potentially inhibiting the function of the CYP60 protein. | ||||||
Clotrimazole | 23593-75-1 | sc-3583 sc-3583A | 100 mg 1 g | $42.00 $57.00 | 6 | |
Clotrimazole is another antifungal medication that inhibits cytochrome P450 enzymes. Its mechanism of action is similar to ketoconazole, where it interferes with the activity of CYP60 isoforms, potentially leading to inhibition of the CYP60 protein through disruption of metabolic pathways. | ||||||
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $78.00 $142.00 | 23 | |
Itraconazole is an antifungal agent that inhibits cytochrome P450 enzymes, including some CYP60 isoforms. Similar to ketoconazole and clotrimazole, it disrupts the activity of CYP60 enzymes, potentially interfering with the function of the CYP60 protein by affecting metabolic pathways. | ||||||
Fluconazole | 86386-73-4 | sc-205698 sc-205698A | 500 mg 1 g | $54.00 $84.00 | 14 | |
Fluconazole, another antifungal medication, also inhibits cytochrome P450 enzymes, including certain CYP60 isoforms. Its mechanism of action involves interference with CYP60 enzyme activity, which may lead to inhibition of the CYP60 protein by disrupting metabolic pathways. | ||||||
Miconazole | 22916-47-8 | sc-204806 sc-204806A | 1 g 5 g | $66.00 $160.00 | 2 | |
Miconazole, an antifungal agent, inhibits cytochrome P450 enzymes, including those within the CYP60 family. By interfering with CYP60 enzyme activity, miconazole can potentially inhibit the function of the CYP60 protein by disrupting metabolic pathways. | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $318.00 | 9 | |
Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) used as an antidepressant. It has been reported to inhibit certain cytochrome P450 enzymes, which may include CYP60 isoforms. By interfering with CYP60 activity, fluoxetine can potentially inhibit the function of the CYP60 protein. | ||||||
Fluvoxamine | 54739-18-3 | sc-207697 | 25 mg | $321.00 | 1 | |
Fluvoxamine, another SSRI antidepressant, inhibits cytochrome P450 enzymes, potentially including some CYP60 isoforms. Its mechanism of action involves interference with CYP60 enzyme activity, which can lead to inhibition of the CYP60 protein by disrupting metabolic pathways. | ||||||
Ritonavir | 155213-67-5 | sc-208310 | 10 mg | $124.00 | 7 | |
Ritonavir is a protease inhibitor. It inhibits cytochrome P450 enzymes, including certain CYP60 isoforms. By interfering with CYP60 activity, ritonavir can potentially inhibit the function of the CYP60 protein by disrupting metabolic pathways. | ||||||
Erythromycin | 114-07-8 | sc-204742 sc-204742A sc-204742B sc-204742C | 5 g 25 g 100 g 1 kg | $57.00 $245.00 $831.00 $1331.00 | 4 | |
Erythromycin is a macrolide antibiotic that inhibits cytochrome P450 enzymes, which may include certain CYP60 isoforms. Its mechanism of action involves interference with CYP60 enzyme activity, potentially leading to inhibition of the CYP60 protein by disrupting metabolic pathways. | ||||||
Cimetidine | 51481-61-9 | sc-202996 sc-202996A | 5 g 10 g | $62.00 $86.00 | 1 | |
Cimetidine is a histamine H2 receptor antagonist. By interfering with CYP60 activity, cimetidine can potentially inhibit the function of the CYP60 protein by disrupting metabolic pathways. | ||||||